B5H-25537-28417
4 vaccinations
1 coded response
45 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 835 / ID
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Dose 1 — Moderna
-
2021-02-02
Registered in v-safe
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-07
- 2021-02-08
- 2021-02-15
- 2021-02-22
-
2021-03-01
Dose 2 — Moderna
- 2021-03-01
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-05-31
- 2021-08-30
-
2021-10-30
Dose 3 — Moderna
- 2021-10-30
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2021-12-13
- 2022-01-31
- 2022-04-30
-
2022-10-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-30
- 2022-10-30
- 2022-11-04
- 2022-11-13
- 2022-11-18
-
2022-11-27
Survey response — day 42, dose 4MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: FairFree text: Cold symptoms, negative CovidMedDRA releases: 2024-11 · check-in free text available
- 2023-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Moderna | |
| 2 | 2021-03-01 | Moderna | |
| 3 | 2021-10-30 | Moderna | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | Flu |
Free text
Release 12 — day 42, dose 4
Symptoms: Cold symptoms, negative Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release